Gastritis, Gut Issues, Neurastenia

Case Study: Addressing Chronic Gastritis, Gut Dysfunction, and Neurasthenia with coMra Therapy

A 55-year-old female patient presented for examination reporting persistent heaviness and dull, cramping pain in the stomach area following meals. Her symptoms included periodic belching and heartburn, particularly on an empty stomach. Due to the discomfort, she struggled to eat, limiting herself to very small portions. Additionally, she reported poor sleep quality, increased irritability, and constant anxiety regarding her health.

Medical History and Context

The patient’s health challenges began approximately one year prior, following an intensive course of drug treatment for a lung condition. While the lung disease was successfully cured, the patient experienced severe stress due to a poor tolerance of the medication. During this period of strong antibiotic use, she began to notice the onset of her current gastrointestinal complaints.

Although she had previously undergone medical treatment that provided temporary relief, her symptoms consistently returned during the spring and autumn months, or whenever she experienced periods of high stress. To manage these flare-ups, she relied on symptomatic treatments such as omeprazole or herbal blends, as she preferred to avoid long-term pharmaceutical intervention.

Diagnosis and coMra Treatment Plan

Following a comprehensive examination, the patient was diagnosed with: Chronic superficial gastritis (in remission, previously associated with Helicobacter pylori* which had been eradicated without relapse). * First-degree gastrocardiac insufficiency. * Functional disorder of the biliary system. * Irritable bowel syndrome (IBS) with a tendency toward constipation. * Neurasthenia.

To address these conditions, a personalized treatment plan using coMra therapy was implemented.

Clinical Outcomes

By the end of the treatment course, both the patient and the attending physician noted significant improvement. The patient’s sleep quality and appetite were restored, allowing her to consume a more diverse diet with increased portion sizes. The pain and heaviness in her stomach were resolved, and she no longer suffered from heartburn or belching. Furthermore, her irritability and anxiety decreased substantially, and her preoccupation with her health concerns diminished.

To maintain these results, the patient was advised to undergo a course of 15 to 21 coMra treatments once per quarter throughout the year, with additional sessions recommended during the spring months to support her system during seasonal transitions.